CH437327A - Verfahren zur Herstellung von neuen 5,6,7,8-Tetrahydropyrido (4,3-d) pyrimidinen - Google Patents

Verfahren zur Herstellung von neuen 5,6,7,8-Tetrahydropyrido (4,3-d) pyrimidinen

Info

Publication number
CH437327A
CH437327A CH302963A CH302963A CH437327A CH 437327 A CH437327 A CH 437327A CH 302963 A CH302963 A CH 302963A CH 302963 A CH302963 A CH 302963A CH 437327 A CH437327 A CH 437327A
Authority
CH
Switzerland
Prior art keywords
tetrahydropyrido
pyrimidines
preparation
new
Prior art date
Application number
CH302963A
Other languages
English (en)
Inventor
Ohnacker Gerhard Dr Dipl-Chem
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of CH437327A publication Critical patent/CH437327A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH302963A 1962-03-22 1963-03-11 Verfahren zur Herstellung von neuen 5,6,7,8-Tetrahydropyrido (4,3-d) pyrimidinen CH437327A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DET21813A DE1197466B (de) 1962-03-22 1962-03-22 Verfahren zur Herstellung von neuen 5, 6, 7, 8-Tetrahydropyrido-[4, 3-d]pyrimidinen

Publications (1)

Publication Number Publication Date
CH437327A true CH437327A (de) 1967-06-15

Family

ID=7550280

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1780166A CH462186A (de) 1962-03-22 1963-03-11 Verfahren zur Herstellung von neuen 5,6,7,8-Tetrahydro-pyrido(4,3-d)pyrimidinen
CH302963A CH437327A (de) 1962-03-22 1963-03-11 Verfahren zur Herstellung von neuen 5,6,7,8-Tetrahydropyrido (4,3-d) pyrimidinen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1780166A CH462186A (de) 1962-03-22 1963-03-11 Verfahren zur Herstellung von neuen 5,6,7,8-Tetrahydro-pyrido(4,3-d)pyrimidinen

Country Status (5)

Country Link
US (1) US3248395A (de)
CH (2) CH462186A (de)
DE (1) DE1197466B (de)
FR (1) FR2450M (de)
GB (1) GB1033384A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725405A (en) * 1970-06-18 1973-04-03 American Home Prod 2,4,7-TRISUBSTITUTED-{8 PYRIDO 2,3-d{9 PYRIMIDINE-6-CARBOXAMIDES
US3939268A (en) * 1971-04-10 1976-02-17 Boehringer Ingelheim Gmbh 2,4-Diamino substituted pyridol(3,2-d)pyrimidine as antithrombotic agents
JPS5130077B2 (de) * 1971-12-28 1976-08-30
US4085102A (en) * 1974-11-25 1978-04-18 E. R. Squibb & Sons, Inc. 2-Amino-8-arylideno-3,4,5,6,7,8-hexahydro-4-arlypyrido[4,3-d]pyrimidines
US5137890A (en) * 1990-02-14 1992-08-11 Ortho Pharmaceutical Corporation 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
US5059602A (en) * 1990-08-27 1991-10-22 Hoechst-Roussel Pharmaceuticals Inc. 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
US5212310A (en) * 1991-12-19 1993-05-18 Neurogen Corporation Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
EP1679668B1 (de) * 1996-09-04 2010-01-27 Intertrust Technologies Corp. Zuverlässige Infrastrukturhilfssysteme, Verfahren und Techniken für sicheren elektronischen Handel, elektronische Transaktionen, Handelsablaufsteuerung und Automatisierung, verteilte Verarbeitung und Rechteverwaltung
WO2002088079A2 (en) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
US7105667B2 (en) * 2001-05-01 2006-09-12 Bristol-Myers Squibb Co. Fused heterocyclic compounds and use thereof
AU2003242252A1 (en) * 2002-06-07 2003-12-22 Kyowa Hakko Kogyo Co., Ltd. Bicyclic pyrimidine derivatives
AR045445A1 (es) * 2003-08-05 2005-10-26 Vertex Pharma Compuestos ihinibidores de canales ionicos regulados por voltaje
MXPA06003150A (es) * 2003-09-17 2006-08-31 Johnson & Johnson Compuestos heterociclicos fusionados.
CA2606760C (en) * 2005-05-04 2014-12-23 Renovis, Inc. Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and disfunctions
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
US8071766B2 (en) 2008-02-01 2011-12-06 Takeda Pharmaceutical Company Limited HSP90 inhibitors
UA101676C2 (uk) * 2008-07-31 2013-04-25 Дженентек, Инк. Піримідинові сполуки, композиції і способи застосування
WO2010120991A1 (en) * 2009-04-17 2010-10-21 Wyeth Llc 5, 6, 7, 8-tetrahydropyrido[4,3-d]pyrimidine compounds, their use as mtor, pi3, and hsmg-1 kinase inhibitors, and their syntheses
CA2766151A1 (en) * 2009-06-24 2010-12-29 Genentech, Inc. Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
WO2011022213A1 (en) 2009-08-17 2011-02-24 Merck Sharp & Dohme Corp. Amino tetrahydro-pyridopyrimidine pde10 inhibitors
KR101447789B1 (ko) * 2009-11-12 2014-10-06 에프. 호프만-라 로슈 아게 Ｎ-7 치환된 퓨린 및 피라졸로피리미딘 화합물, 조성물 및 사용 방법
MX2012005463A (es) * 2009-11-12 2012-09-12 Hoffmann La Roche Compuestos de purina n/9 sustituida, composiciones y metodos de uso.
UA112517C2 (uk) 2010-07-06 2016-09-26 Новартіс Аг Тетрагідропіридопіримідинові похідні

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2697710A (en) * 1953-01-02 1954-12-21 Burroughs Wellcome Co Pyrido (2,3-d) pyrimidines and method of preparing same
US2926166A (en) * 1954-01-04 1960-02-23 Burroughs Wellcome Co Pyrido (2, 3-d) pyrimidine compounds and method of making
US2802826A (en) * 1955-07-13 1957-08-13 Hoffmann La Roche Octahydro-pyrido [4, 3-d] pyrimidine compounds
US2890152A (en) * 1956-11-29 1959-06-09 Schering Corp Topical anti-inflammatory compositions
US2994640A (en) * 1957-02-22 1961-08-01 Byk Gulden Lomberg Chem Fab Anti-inflammatory therapy with purine molecular compounds
DE1110649B (de) * 1957-11-22 1961-07-13 Ciba Geigy Verfahren zur Herstellung von 1-Isopropyl-pyrazolo[3, 4-d]pyrimidinen

Also Published As

Publication number Publication date
CH462186A (de) 1968-09-15
FR2450M (fr) 1964-04-06
US3248395A (en) 1966-04-26
GB1033384A (en) 1966-06-22
DE1197466B (de) 1965-07-29

Similar Documents

Publication Publication Date Title
CH446361A (de) Verfahren zur Herstellung von neuen Thieno(3,2-d)pyrimidinen
CH437327A (de) Verfahren zur Herstellung von neuen 5,6,7,8-Tetrahydropyrido (4,3-d) pyrimidinen
CH453340A (de) Verfahren zur Herstellung von trans-Dimethylolcyclohexan-1,4
CH438343A (de) Verfahren zur Herstellung von 5,6-Dihydro-6-oxo-11H-pyrido (2,3-b) (1,4)-benzodiazepinen
CH457472A (de) Verfahren zur Herstellung von neuen 5,6,7,8-Tetrahydro-pyrido(4,3-d)pyrimidinen
CH438344A (de) Verfahren zur Herstellung von basisch substituierten Pyrimido (5,4-d)-pyrimidinen
CH382178A (de) Verfahren zur Herstellung von substituierten 2,4-Diamino-7-oxy-pyrido (2,3-d) pyrimidinen
AT251599B (de) Verfahren zur Herstellung von neuen 2-Guanidinoalkyl-1,4-benzodioxanen
CH453374A (de) Verfahren zur Herstellung von neuen 5,6-Dihydro-11H-pyrido(2,3-b) (1,5)benzodiazepinen
CH435305A (de) Verfahren zur Herstellung von neuen 5,6,7,8-Tetrahydropyrido (4,3-d)pyrimidinen
CH441346A (de) Verfahren zur Herstellung von neuen 5H-Dihydrothiopyrano-(4,3-d)-pyrimidinen
CH446358A (de) Verfahren zur Herstellung von neuen Dihydrothieno(3,2-d)pyrimidinen
CH438346A (de) Verfahren zur Herstellung von neuen 5,6-Dihydro-5-oxo-11H-pyrido (2,3-b) (1,5) benzodiazepinen
CH414657A (de) Verfahren zur Herstellung von 2,4-Diamino-pyrido(2,3-d)pyrimidinen
CH469737A (de) Verfahren zur Herstellung von neuen 4H-m-Dithiino(5,4-d)pyrimidinen
CH457474A (de) Verfahren zur Herstellung von 2,4-Diamino-7-chlorpyrido(2,3-d)pyrimidinen
CH453370A (de) Verfahren zur Herstellung von neuen 5,6-Dihydro-6-oxo-pyrido (2,3-b)(1,4)benzoxazepinen
AT256088B (de) Verfahren zur Herstellung von neuen basisch substituierten Naphthalin-(1,4,5,8)-tetracarbonsäurediimiden
CH481939A (de) Verfahren zur Herstellung von 4H-Pyrazino-(2,3-d)-(1,3)-oxazin-4-onen
CH430704A (de) Verfahren zur Herstellung von 4,7-Dihalogen-1-methylindan-3-onen
CH469729A (de) Verfahren zur Herstellung von neuen 4,9-Dihydrothieno-(2,3-b)-benzo-(e)-thiepinderivaten
AT248445B (de) Verfahren zur Herstellung von neuen 1, 2-Dimehtylhexahydropyridazinen
CH442306A (de) Verfahren zur Herstellung von 3,4-Dihydro-benzoxazinonen-(1,3,2)
AT245575B (de) Verfahren zur Herstellung von neuen 3,8-Diazabicyclo-[3,2,1]-octanen
CH450442A (de) Verfahren zur Herstellung von neuen 5,6-Dihydro-11H-pyrido(2,3-b)(1,4)benzodiazepinen